SBS Code
stringlengths 9
11
| SBS Code (Hyphenated)
stringlengths 11
12
| Short Description
stringlengths 3
74
| Long Description
stringlengths 7
544
| Chapter
float64 1
25
⌀ | Chapter Name
stringclasses 25
values | Block
int64 1
4.02k
| Block Name
stringlengths 3
99
⌀ | Definition
stringlengths 11
1.18k
⌀ | Includes
stringlengths 4
1.31k
⌀ | Excludes
stringlengths 1
1.23k
⌀ | Guidelines
stringlengths 1
1.54k
⌀ |
|---|---|---|---|---|---|---|---|---|---|---|---|
733000310 | 73300-03-10 | Tiagabine; Quant. | Quantitative measurement of drug Tiagabine Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Tiagabine quantification | null | null | null |
733000320 | 73300-03-20 | Tobramycin; Quant. | Quantitative measurement of drug Tobramycin Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Tobramycin quantification (antibiotic) | null | null | null |
733000330 | 73300-03-30 | Topiramate; Quant. | Quantitative measurement of drug Topiramate Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Tobramycin quantification (anticonvulsant) | null | null | null |
733000340 | 73300-03-40 | Vancomycin; Quant. | Quantitative measurement of drug Vancomycin Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Vancomycin quantification (antibiotic) | null | null | null |
733000350 | 73300-03-50 | Zonisamide; Quant. | Quantitative measurement of drug Zonisamide Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Zonisamide quantification (e.g. for appropriate dosing for treating seizures) | null | null | null |
733000360 | 73300-03-60 | Over-the-counter (OTC) Drug Levels; Quant. | Quantitative measurement of Over-the-counter (OTC) drug Levels | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Over-the-counter drug quantification | null | null | null |
733000370 | 73300-03-70 | Unlist Quantitative Drug Test | Unlisted Quantitative Therapeutic Drug Test | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Unlisted or unspecified quantitative therapeutic drug test | null | null | null |
733000380 | 73300-03-80 | PRSMV Drug (DIR OPT) | Presumptive drug test (any method); result read by direct optical observation | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Presumptive drug testing procedure, utilizing any method that require result reading by direct optical observation (e.g. immunoassay, including dipsticks, cards, cups, cartridges) (This test is ordered for suspected drug overdose. it is NOT sufficient to identify drug classes; therefore follow up tests may be ordered for definitive drug testing) | null | null | Assign one code for each date of service. Do not code or bill for sample validation techniques such as urinalysis in addition to this code |
733000390 | 73300-03-90 | PRSMV Drug (INS ASSIT) | Presumptive drug test (any method); result read by instrument–assisted direct optical observation | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Presumptive drug tests utilizing any method requiring result reading by instrument–assisted direct optical observation (e.g. immunoassay, including dipsticks, cards, cups, cartridges) (This test is ordered for suspected drug overdose. it is NOT sufficient to identify drug classes; therefore follow up tests may be ordered for definitive drug testing) | null | null | Assign one code for each date of service. Do not code or bill for sample validation techniques such as urinalysis in addition to this code |
733000400 | 73300-04-00 | PRSMV Drug (CHEM ANLYZ) | Presumptive drug test (any number of drugs) by instrumented chemistry analyzers | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Presumptive drug screen utilizing instrumented chemistry analyzers (e.g. immunoassays (ELISA) or others, gas or liquid chromatography, mass spectrometry (MS)) (This test is ordered for suspected drug overdose. it is NOT sufficient to identify drug classes; therefore follow up tests may be ordered for definitive drug testing) | null | null | Assign one code for each date of service. Do not code or bill for sample validation techniques such as urinalysis in addition to this code |
733000410 | 73300-04-10 | Alcohols; Quant./Qual. | Quantitative/Qualitative measurement of Alcohol | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Alcohol identification in blood, body fluids, or tissue (e.g. Intoxication screening) | null | null | null |
733000420 | 73300-04-20 | Alcohols ; 1-2 Biomarkers; Quant./Qual. | Quantitative/Qualitative measurement of (1-2) Alcohol Biomarkers | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Alcohol identification in patient specimen, biomarkers indicates alcohol exposure/ingestion | null | null | null |
733000430 | 73300-04-30 | Alcohols ; ≥ 3 Biomarkers; Quant./Qual | Quantitative/Qualitative measurement of (3 or more) Alcohol Biomarkers | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Alcohol identification in patient specimen, biomarkers indicates alcohol exposure/ingestion | null | null | null |
733000440 | 73300-04-40 | Allerfin; Quant./Qual. | Quantitative/Qualitative measurement of Allerfin | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Allerfin identification | null | null | null |
733000450 | 73300-04-50 | Amphetamines ; 1-2; Quant./Qual. | Quantitative/Qualitative measurement of 1-2 Amphetamines Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Amphetamines identification (e.g. initial drug abuse screen) | null | null | null |
733000460 | 73300-04-60 | Amphetamines ; 3-4; Quant./Qual. | Quantitative/Qualitative measurement of 3-4 Amphetamines Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Amphetamines identification (e.g. initial drug abuse screen) | null | null | null |
733000470 | 73300-04-70 | Amphetamines ; ≥5; Quant./Qual. | Quantitative/Qualitative measurement of 5 or more Amphetamines Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Amphetamines identification (e.g. initial drug abuse screen) | null | null | null |
733000480 | 73300-04-80 | Anabolic Steroids ; 1-2; Quant./Qual. | Quantitative/Qualitative measurement of 1-2 Anabolic Steroids Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Anabolic steroids identification (male sex hormone testosterone; e.g. initial drug abuse screen) | null | null | null |
733000490 | 73300-04-90 | Anabolic Steroids ; ≥ 3; Quant./Qual. | Quantitative/Qualitative measurement of 3 or more Anabolic Steroids Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Anabolic steroids identification (male sex hormone testosterone; e.g. initial drug abuse screen) | null | null | null |
733000500 | 73300-05-00 | Tenoxicam; Quant./Qual. | Quantitative/Qualitative measurement of Tenoxicam | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Tenoxicam Assay identification | null | null | null |
733000505 | 73300-05-05 | Non-opioid analgesics; 1-2 ; Quant./Qual. | Quantitative/Qualitative measurement of 1-2 non-opioid Analgesics Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Non-opioid Analgesics identification (pain medication; e.g. initial drug abuse screen) | null | null | null |
733000510 | 73300-05-10 | Non-opioid analgesics; 3-5 ; Quant./Qual. | Quantitative/Qualitative measurement of 3-5 non-opioid Analgesics Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Non-opioid Analgesics identification (pain medication; e.g. initial drug abuse screen) | null | null | null |
733000520 | 73300-05-20 | Non-Opioid Analgesics ; ≥6 ; Quant./Qual. | Quantitative/Qualitative measurement of 6 or more non-opioid Analgesics Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Non-opioid Analgesics identification (pain medication; e.g. initial drug abuse screen) | null | null | null |
733000530 | 73300-05-30 | Serotonergic Antidepressants; 1-2 ; Quant./Qual. | Quantitative/Qualitative measurement of 1-2 Serotonergic Antidepressants Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Serotonergic Antidepressants identification (e.g. medication compliance or overdose) | null | null | null |
733000540 | 73300-05-40 | Serotonergic Antidepressants; 3-5 ; Quant./Qual. | Quantitative/Qualitative measurement of 3-5 Serotonergic Antidepressants Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Serotonergic Antidepressants identification (e.g. medication compliance or overdose) | null | null | null |
733000550 | 73300-05-50 | Serotonergic Antidepressants; ≥6 ; Quant./Qual. | Quantitative/Qualitative measurement of 6 or more Serotonergic Antidepressants Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Serotonergic Antidepressants identification (e.g. medication compliance or overdose) | null | null | null |
733000560 | 73300-05-60 | Cyclical Antidepressants; 1-2 ; Quant./Qual. | Quantitative/Qualitative measurement of 1-2 cyclical antidepressants analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Cyclical Antidepressants identification (e.g. medication compliance or overdose) | null | null | null |
733000570 | 73300-05-70 | Cyclical Antidepressants; 3-5 ; Quant./Qual. | Quantitative/Qualitative measurement of 3-5 cyclical antidepressants analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Cyclical Antidepressants identification (e.g. medication compliance or overdose) | null | null | null |
733000580 | 73300-05-80 | Cyclical Antidepressants; ≥6 ; Quant./Qual. | Quantitative/Qualitative measurement of 6 or more cyclical antidepressants analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Cyclical Antidepressants identification (e.g. medication compliance or overdose) | null | null | null |
733000590 | 73300-05-90 | Unspec Antidepressants; Quant./Qual. | Quantitative/Qualitative measurement of unspecified antidepressants | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Unlisted or unspecified Antidepressants identification (e.g. medication compliance or overdose) | null | null | null |
733000600 | 73300-06-00 | Unspec Antiepileptics ; 1-3 ; Quant./Qual. | Quantitative/Qualitative measurement of 1-3 Antiepileptics Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Unlisted or unspecified Antiepileptics identification (anticonvulsant/antiseizure; e.g. medication compliance or overdose) | null | null | null |
733000610 | 73300-06-10 | Unspec Antiepileptics ; 4-6 ; Quant./Qual. | Quantitative/Qualitative measurement of 4-6 Antiepileptics Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Unlisted or unspecified Antiepileptics identification (anticonvulsant/antiseizure; e.g. medication compliance or overdose) | null | null | null |
733000620 | 73300-06-20 | Unspec Antiepileptics ; ≥7 ; Quant./Qual. | Quantitative/Qualitative measurement of 7 or more Antiepileptics Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Unlisted or unspecified Antiepileptics identification (anticonvulsant/antiseizure; e.g. medication compliance or overdose) | null | null | null |
733000630 | 73300-06-30 | Unspec Antipsychotics ; 1-3 ; Quant./Qual. | Quantitative/Qualitative measurement of 1-3 Antipsychotics | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Unlisted or unspecified Antipsychotics identification (e.g. medication compliance or overdose) | null | null | null |
733000640 | 73300-06-40 | Unspec Antipsychotics ; 4-6 ; Quant./Qual. | Quantitative/Qualitative measurement of 4-6 Antipsychotics | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Unlisted or unspecified Antipsychotics identification (e.g. medication compliance or overdose) | null | null | null |
733000650 | 73300-06-50 | Unspec Antipsychotics ; ≥7 ; Quant./Qual. | Quantitative/Qualitative measurement of 7 or more Antipsychotics | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Unlisted or unspecified Antipsychotics identification (e.g. medication compliance or overdose) | null | null | null |
733000660 | 73300-06-60 | Barbiturates; Quant./Qual. | Quantitative/Qualitative measurement of Barbiturates | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Barbiturates identification (seizures /convulsion; e.g. medication compliance or overdose) | null | null | null |
733000670 | 73300-06-70 | Benzodiazepines ; 1-12 ; Quant./Qual. | Quantitative/Qualitative measurement of 1-12 Benzodiazepines Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Benzodiazepines identification (tranquilizers; e.g. medication compliance or overdose) | null | null | null |
733000680 | 73300-06-80 | Benzodiazepines ; ≥13 ; Quant./Qual. | Quantitative/Qualitative measurement of 13 or more Benzodiazepines Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Benzodiazepines identification (tranquilizers; e.g. medication compliance or overdose) | null | null | null |
733000690 | 73300-06-90 | Buprenorphine; Quant./Qual. | Quantitative/Qualitative measurement of Buprenorphine | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Buprenorphine identification (e.g. treat opioid addiction; pain reliever) | null | null | null |
733000700 | 73300-07-00 | Natural Cannabinoids; Quant./Qual. | Quantitative/Qualitative measurement of Natural Cannabinoids | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Natural Cannabinoids identification (e.g. medication compliance or overdose) | null | null | null |
733000710 | 73300-07-10 | Synthetic Cannabinoids ; 1-3 ; Quant./Qual. | Quantitative/Qualitative measurement of 1-3 Synthetic Cannabinoids Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Synthetic Cannabinoids identification (e.g. medication compliance or overdose) | null | null | null |
733000720 | 73300-07-20 | Synthetic Cannabinoids ; 4-6 ; Quant./Qual. | Quantitative/Qualitative measurement of 4-6 Synthetic Cannabinoids Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Synthetic Cannabinoids identification (e.g. medication compliance or overdose) | null | null | null |
733000730 | 73300-07-30 | Synthetic Cannabinoids ; ≥7 ; Quant./Qual. | Quantitative/Qualitative measurement of 7 or more Synthetic Cannabinoids Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Synthetic Cannabinoids identification (e.g. medication compliance or overdose) | null | null | null |
733000740 | 73300-07-40 | Cocaine; Quant./Qual. | Quantitative/Qualitative measurement of Cocaine | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Cocaine Screening (presence and amount in specimen) | null | null | null |
733000750 | 73300-07-50 | Fentanyl; Quant./Qual. | Quantitative/Qualitative measurement of Fentanyl | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Fentanyl identification (medication compliance or overdose) | null | null | null |
733000760 | 73300-07-60 | Gabapentin; Quant./Qual. ; Non-Blood | Quantitative/Qualitative measurement of Non-Blood Gabapentin | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Non-Blood Gabapentin identification (e.g analgesic; neuropathic pain). | null | null | null |
733000770 | 73300-07-70 | Heroin; Quant./Qual. | Quantitative/Qualitative measurement of Heroin Metabolite | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Heroin Metabolite identification (e.g overdose). | null | null | null |
733000780 | 73300-07-80 | Ketamine/Norketamine; Quant./Qual. | Quantitative/Qualitative measurement of Ketamine and Norketamine | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Ketamine/Norketamine identification (e.g overdose). | null | null | null |
733000790 | 73300-07-90 | Methadone; Quant./Qual. | Quantitative/Qualitative measurement of Methadone | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Methadone identification (e.g treatment of heroine addiction) | null | null | null |
733000800 | 73300-08-00 | Methylenedioxyamphetamine; Quant./Qual. | Quantitative/Qualitative measurement of Methylenedioxyamphetamine (MDA, MDEA, MDMA) | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Methylenedioxyamphetamine identification (e.g overdose) | null | null | null |
733000810 | 73300-08-10 | Methylphenidate; Quant./Qual. | Quantitative/Qualitative measurement of Methylphenidate | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Methylphenidate identification (stimulant; e.g attention defects treatment) | null | null | null |
733000820 | 73300-08-20 | Opiates ; ≥1 ; Quant./Qual. | Quantitative/Qualitative measurement of 1 or more Opiate Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Opiates identification (narcotic analgesics; e.g, medication compliance, overdose) | null | null | null |
733000830 | 73300-08-30 | Opioids &Analogs ; 1-2 ; Quant./Qual. | Quantitative/Qualitative measurement of 1-2 Opioids and Opiate Analogs Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Opioids and Opiate Analogs identification (narcotic analgesics; e.g, medication compliance, overdose) | null | null | null |
733000840 | 73300-08-40 | Opioids &Analogs ; 3-4 ; Quant./Qual. | Quantitative/Qualitative measurement of 3-4 Opioids and Opiate Analogs Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Opioids and Opiate Analogs identification (narcotic analgesics; e.g, medication compliance, overdose) | null | null | null |
733000850 | 73300-08-50 | Opioids &Analogs ; ≥5 ; Quant./Qual. | Quantitative/Qualitative measurement of 5 or more Opioids and Opiate Analogs Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Opioids and Opiate Analogs identification (narcotic analgesics; e.g, medication compliance, overdose) | null | null | null |
733000860 | 73300-08-60 | Oxycodone; Quant./Qual. | Quantitative/Qualitative measurement of Oxycodone | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Oxycodone identification (synthetic opioid pain medication; e.g, medication compliance, overdose) | null | null | null |
733000870 | 73300-08-70 | Pregabalin; Quant./Qual. | Quantitative/Qualitative measurement of Pregabalin | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Pregabalin identification (treats nerve pain and seizures; e.g. test for medication compliance, overdose) | null | null | null |
733000880 | 73300-08-80 | Propoxyphene; Quant./Qual. | Quantitative/Qualitative measurement of Propoxyphene | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Propoxyphene identification (narcotic analgesic; e.g. test for medication compliance, overdose) | null | null | null |
733000890 | 73300-08-90 | Sedative Hypnotics; Quant./Qual. | Quantitative/Qualitative measurement of Sedative Hypnotics (non-benzodiazepines) | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Sedative hypnotics identification (e.g. test for medication compliance, overdose) | null | null | null |
733000900 | 73300-09-00 | Skeletal Muscle Relaxants ; 1-2 ; Quant./Qual. | Quantitative/Qualitative measurement of 1-2 Skeletal Muscle Relaxants Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Skeletal Muscle Relaxants identification (muscle spasm and pain; e.g. test for medication compliance, overdose) | null | null | null |
733000910 | 73300-09-10 | Skeletal Muscle Relaxants ; ≥3 ; Quant./Qual. | Quantitative/Qualitative measurement of 3 or more Skeletal Muscle Relaxants Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Skeletal Muscle Relaxants identification (muscle spasm and pain; e.g. test for medication compliance, overdose) | null | null | null |
733000920 | 73300-09-20 | Synthetic Stimulant; Quant./Qual. | Quantitative/Qualitative measurement of Synthetic Stimulants (bath salts) | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Synthetic Stimulant identification (stimulate excitement/happiness; e.g. test for medication compliance, overdose) | null | null | null |
733000930 | 73300-09-30 | Tapentadol; Quant./Qual. | Quantitative/Qualitative measurement of Tapentadol | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Tapentadol identification (opioid pain medication; e.g. test for medication compliance, overdose) | null | null | null |
733000940 | 73300-09-40 | Tramadol; Quant./Qual. | Quantitative/Qualitative measurement of Tramadol | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Tramadol identification (opioid pain medication; e.g. test for medication compliance, overdose) | null | null | null |
733000950 | 73300-09-50 | Stereoisomer; single drug; Quant./Qual. | Quantitative/Qualitative measurement of Stereoisomers (enantiomers) for a single drug | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Stereoisomers identification (e.g. identification of enantiomer unseful to the body) | null | null | null |
733000960 | 73300-09-60 | Betamethasone; Quant./Qual. | Quantitative/Qualitative measurement of Betamethasone | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Betamethasone identification | null | null | null |
733000970 | 73300-09-70 | Other Drug/Substance ; 4-6 ; Quant./Qual. | Quantitative/Qualitative measurement of 4-6 Drug or Substance Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Unspecified Drug/Substance identification (e.g. verification of drug presence/amount in the body) | null | null | null |
733000980 | 73300-09-80 | Other Drug/Substance ; ≥7 ; Quant./Qual. | Quantitative/Qualitative measurement of 7 or more Drug or Substance Analytes | 21 | Laboratory and Pathology | 3,300 | Drug Assays & Chemical toxicology | Unspecified Drug/Substance identification (e.g. verification of drug presence/amount in the body) | null | null | null |
733500109 | 73350-01-09 | ABL1 gene; variants | ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1) gene analysis of Kinase domain variants | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for ABL1 gene mutations (e.g. acquired imatinib tyrosine kinase inhibitor resistance) | null | null | null |
733500032 | 73350-00-32 | AFF2 gene; Evaluation | AF4/FMR2 family, member 2 [FMR2] expanded sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for abnormal expanded allels (e.g. fragile X, mental retardation 2) | null | null | If the assay includes allele characterization do not separately assign (AFF2 Gene; Characterization). |
733500033 | 73350-00-33 | AFF2 gene; Characterization | AF4/FMR2 family, member 2 [FMR2] characterization of expanded sequence abnormal alleles | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Characterization of abnormal alleles (e.g. methylation and nucleotide repeats detection) following abnormality detection (e.g. fragile X, mental retardation 2) | null | null | null |
733500034 | 73350-00-34 | APC gene; Full Sequence | Adenomatous polyposis coli (APC) full sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Full sequencing of APC gene (e.g. familial adenomatosis polyposis) | null | null | null |
733500035 | 73350-00-35 | APC gene; Familial variant | Adenomatous polyposis coli (APC) analysis of common familial variant | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of specific familial gene sequence alteration (variant/mutation) (e.g. familial adenomatosis polyposis) | null | null | null |
733500036 | 73350-00-36 | APC gene; Dup/Del | Adenomatous polyposis coli (APC) duplication and deletion analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for APC gene (e.g. familial adenomatosis polyposis) | null | null | null |
733500037 | 73350-00-37 | AR gene; Characterization | Androgen receptor (AR) characterization of expanded sequence abnormal alleles | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Follow up gene analysis to define nucleotide repeats or methylation status (e.g. spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) | null | null | null |
733500038 | 73350-00-38 | AR gene; Full Sequence | Androgen receptor (AR) full sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Full sequencing of AR gene (e.g. spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) | null | null | null |
733500039 | 73350-00-39 | AR gene; Familial variant | Androgen receptor (AR) analysis of specific familial variant | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of specific familial gene sequence alteration (variant/mutation) (e.g. spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) | null | null | null |
733500093 | 73350-00-93 | ASPA gene; variants | Aspartoacylase (ASPA) common gene variants analysis (e.g. E285A, Y231X) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Molecular testing for ASPA gene (e.g. Canavan disease) | null | null | null |
733500094 | 73350-00-94 | ASXL1 gene; Full Sequence | Additional sex combs like 1, transcriptional regulator (ASXL1) full sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Molecular testing for ASXL1 gene (e.g. myelodysplastic syndrome) | null | null | null |
733500095 | 73350-00-95 | ASXL1 gene; Target Sequence | Additional sex combs like 1, transcriptional regulator (ASXL1) targeted sequence analysis (e.g. exon 12) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Molecular testing for target sequence of the ASXL1 gene (e.g. myelodysplastic syndrome) | null | null | null |
733500102 | 73350-01-02 | ATN1 gene; Evaluation | Atrophin 1 (ATN1) expanded sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Molecular testing for atN1 gene expanded alleles (e.g. dentatorubral-pallidoluysian atrophy) | null | null | null |
733500103 | 73350-01-03 | ATXN1 gene; Evaluation | Ataxin 1 (ATXN1) expanded sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Molecular testing for atN1 gene (e.g. spinocerebellar ataxia) | null | null | null |
733500104 | 73350-01-04 | ATXN2 gene; Evaluation | Ataxin 2 (ATXN2) expanded sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Molecular testing for atN2 gene (e.g. spinocerebellar ataxia) | null | null | null |
733500105 | 73350-01-05 | ATXN3 gene; Evaluation | Ataxin 3 (ATXN3) expanded sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Molecular testing for atN3 gene (e.g. spinocerebellar ataxia) | null | null | null |
733500106 | 73350-01-06 | ATXN7 gene; Evaluation | Ataxin 7 (ATXN7) expanded sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Molecular testing for atN7 gene (e.g. spinocerebellar ataxia) | null | null | null |
733500107 | 73350-01-07 | ATXN8OS gene; Evaluation | Ataxin 8 opposite strand (ATXN8OS) expanded sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Molecular testing for atN8OS gene (e.g. spinocerebellar ataxia) | null | null | null |
733500108 | 73350-01-08 | ATXN10 gene; Evaluation | Ataxin 10 (ATXN10) expanded sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Molecular testing for atN10 gene (e.g. spinocerebellar ataxia) | null | null | null |
733500096 | 73350-00-96 | BCKDHB gene; variants | Branched-chain keto acid dehydrogenase E1, beta polypeptide (BCKDHB) common gene variants analysis (e.g. R183P, G278S, E422X) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Molecular testing for mutations on the BCKDHB gene (e.g. maple syrup urine disease) | null | null | null |
733500031 | 73350-00-31 | BRAF gene; variants | B-Raf proto-oncogene, serine/threonine kinase (BRAF) common gene variants analysis (e.g. V600) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for BRAF gene mutations (e.g. , colon cancer, melanoma) | null | null | null |
733500091 | 73350-00-91 | BRCA 1 gene; Dup/Del | Breast cancer gene 1 (BRCA1) full duplication and deletion analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for BRCA1 genes (e.g. hereditary breast, ovarian cancer); detection of large gene rearrangements | null | null | null |
733500092 | 73350-00-92 | BRCA 1 gene; Familial variant | Breast cancer gene 1 (BRCA1) analysis of common familial variant | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of specific familial gene sequence alteration (variant/mutation) (e.g. performed for risk assessment of hereditary conditions) | null | null | Do not assign this code with (73350-00-50, 73350-00-60, 73350-05-80) |
733500101 | 73350-01-01 | BRCA 2 gene; Dup/Del | Breast cancer gene 2 (BRCA2) full duplication and deletion analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for BRCA 2 genes (e.g. hereditary breast, ovarian cancer); detection of large gene rearrangements | null | null | null |
733500111 | 73350-01-11 | BTK gene; variants | Bruton's tyrosine kinase (BTK) common gene variants analysis (e.g. C481S, C481R, C481F) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Molecular testing for BTK gene (e.g. chronic lymphocytic leukemia) | null | null | null |
733500112 | 73350-01-12 | CACNA1A gene; Evaluation | Calcium voltage-gated channel subunit alpha1 A (CACNA1A) expanded sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for abnormal expanded alleles (e.g. carrier status determination, spinocerebellar ataxia 6 (SCA6)) | null | null | null |
733500113 | 73350-01-13 | CACNA1A gene; Full sequence | Calcium voltage-gated channel subunit alpha1 A (CACNA1A) full sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Full sequencing of the gene (e.g. carrier status determination, spinocerebellar ataxia 6 (SCA6)) | null | null | null |
733500114 | 73350-01-14 | CACNA1A gene; Familial variant | Calcium voltage-gated channel subunit alpha1 A (CACNA1A) analysis of specific familial variant | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Analysis of specific, familial, gene sequence alteration (variant/mutation) | null | null | null |
733500115 | 73350-01-15 | CALR gene; variants | Calreticulin (CALR) gene analysis of exon 9 variants | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Testing for gene mutation (e.g. thrombocythemia) | null | null | null |
733500116 | 73350-01-16 | CCND1/IGH gene; Quant./Qual. | Quantitative/Qualitative major breakpoint translocation analysis of CCND1/IGH (t(11;14)) | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Major breakpoint due to translocation, forming altered gene sequence (e.g. mantle cell lymphoma) | null | null | null |
733500117 | 73350-01-17 | CEBPA gene; Full sequence | CCAAT/enhancer binding protein, alpha gene (CEBPA) full sequence analysis | 21 | Laboratory and Pathology | 3,350 | Molecular Pathology including Gene Sequencing | Full sequencing of a gene (e.g. acute myeloid leukemia) | null | null | null |